UiPath Q2 Results Reflect Restructuring Benefits, Analysts Praise 'Laser-Focus' On AI

Shares of UiPath Inc PATH are down Friday despite the company's reporting in-line fiscal second-quarter results. Here are some key analyst takeaways: BMO Capital Markets analyst Keith Bachman maintained a Market Perform rating, while raising the price target from $14 to$15. DA Davidson analyst Gil Luria reaffirmed a Neutral rating, while lifting the price target from $13 to$15. JPMorgan analyst Mark Murphy reiterated an Overweight rating and price target of $19. RBC Capital Markets analyst Matthew Hedberg ...